Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Screen-Well ™ Autophagy Compound Library from Enzo Life Sciences enables targeted research on the role of autophagy in various diseases including cancer and neurodegenerative diseases

Dec 2010

Enzo Life Sciences continues to expand its offering of products for Autophagy research with the addition of the Screen-Well™ Autophagy Compound Library.

Autophagy, the process involved in the degradation of a cell’s own components through the lysosomal machinery, plays an important role in cell growth, development and homeostasis. Research on autophagy continues in hopes that further understanding of the process will bring us closer to treating various diseases.

The Screen-Well™ Autophagy compound library is a focused collection of autophagic compounds for cell-based and biochemical applications. It provides a useful tool for studying the roles of pro- and anti-autophagic molecules in cells and for use in in vitro applications. A variety of structurally and mechanistically different compound classes are included.

The Screen-Well™ Autophagy Compound library contains 96 compounds with defined autophagy-inducing or autophagy-inhibiting activity. To ensure high relevancy, each compound of the set is carefully chosen by our experienced chemists and biochemists through an extensive and well established data mining and literature search process. Like Enzo Life Sciences’ other Screen-Well™ Compound Libraries, the Screen-Well™ Autophagy Compound Library is supplied in biocompatible solvents, and no reconstitution is needed before use. For added convenience, individual compounds of the library are available for resupply.

For more information on, or to order, the Screen-Well™ Autophagy Compound Library or other Enzo Life Sciences products, please visit us at or call us at 1-800-942-0430.

About Enzo Life Sciences
Enzo Life Sciences, Inc. is a wholly owned subsidiary of Enzo Biochem, Inc. headquartered in Farmingdale, New York. The company is focused on providing innovative life science research reagents worldwide based on over 30 years of successful experience in building strong international market recognition, implementing outstanding operational capabilities, and establishing a state-of-the-art electronic information and ordering marketplace.

Enzo Life Sciences, Inc. is a recognized leader in labeling and detection technologies across research and diagnostic markets. Our strong portfolio of proteins, antibodies, peptides, small molecules, labeling probes dyes and kits provides life science researchers tools for target identification/validation, high content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.

Now incorporating the skills, experience and products of ALEXIS® Biochemicals, acquired in 2007, BIOMOL® International, acquired in 2008, and ASSAY DESIGNS® and STRESSGEN® acquired in 2009, the Enzo Life Sciences brand now provides 25 years of business experience in the supply of research kits, biochemicals and biologicals “Enabling Discovery in Life Science™”.

For additional Information, please contact:
Kara Cannon; Global Head of Marketing
1-631-694-7070 x 145

Recommend this page